ProShare Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Sell
30,480
-4,910
-14% -$32.6K ﹤0.01% 1620
2025
Q4
$278K Buy
35,390
+3,383
+11% +$26.6K ﹤0.01% 1504
2025
Q3
$261K Sell
32,007
-4,716
-13% -$31.3K ﹤0.01% 1527
2025
Q2
$171K Sell
36,723
-358
-1% -$1.64K ﹤0.01% 1761
2025
Q1
$204K Sell
37,081
-9,472
-20% -$38.2K ﹤0.01% 1674
2024
Q4
$158K Sell
46,553
-24,051
-34% -$77.4K ﹤0.01% 1956
2024
Q3
$201K Buy
70,604
+43,630
+162% +$112K ﹤0.01% 1728
2024
Q2
$60.7K Sell
26,974
-6,614
-20% -$13.3K ﹤0.01% 1722
2024
Q1
$74.2K Buy
33,588
+2,739
+9% +$7.09K ﹤0.01% 1862
2023
Q4
$72.5K Buy
30,849
+4,537
+17% +$8.37K ﹤0.01% 1818
2023
Q3
$48.9K Buy
26,312
+122
+0.5% +$279 ﹤0.01% 1717
2023
Q2
$68.6K Buy
26,190
+1,179
+5% +$3K ﹤0.01% 1742
2023
Q1
$40.8K Buy
+25,011
New +$31.3K ﹤0.01% 1686
2022
Q4
Sell
-26,029
Closed -$41K 1894
2022
Q3
$41K Buy
26,029
+601
+2% +$994 ﹤0.01% 1678
2022
Q2
$39K Buy
25,428
+11,445
+82% +$24.2K ﹤0.01% 1731
2022
Q1
$36K Sell
13,983
-3,578
-20% -$8.74K ﹤0.01% 2140
2021
Q4
$51K Buy
17,561
+3,356
+24% +$7.25K ﹤0.01% 2283
2021
Q3
$35K Buy
14,205
+2,280
+19% +$6.62K ﹤0.01% 1986
2021
Q2
$49K Sell
11,925
-8,539
-42% -$32.6K ﹤0.01% 2359
2021
Q1
$92K Buy
20,464
+2,723
+15% +$14.7K ﹤0.01% 2176
2020
Q4
$87K Buy
17,741
+4,651
+36% +$23.3K ﹤0.01% 2006
2020
Q3
$78K Buy
13,090
+2,010
+18% +$8.04K ﹤0.01% 1551
2020
Q2
$29K Buy
+11,080
New +$38.6K ﹤0.01% 1647
2019
Q4
Sell
-10,344
Closed -$102K 1804
2019
Q3
$102K Buy
10,344
+314
+3% +$3.53K ﹤0.01% 1546
2019
Q2
$115K Sell
10,030
-1,291
-11% -$13.6K ﹤0.01% 1517
2019
Q1
$114K Buy
+11,321
New +$145K ﹤0.01% 1559

Other funds holding XERS